Creates provisions relating to the 340B drug pricing program
If enacted, HB 1977 will have considerable implications for state healthcare policies and pharmacy operations. It specifically prohibits certain discriminatory practices from health carriers and pharmacy benefits managers, such as limiting reimbursements for 340B drugs or imposing stricter terms and conditions on covered entities. This legislation is likely to enhance the financial viability of federally qualified health centers and other covered entities, which rely on the discounts provided under the 340B program to serve underserved populations effectively.
House Bill 1977 aims to amend Chapter 376 of the Revised Statutes of Missouri by introducing new provisions related to the 340B drug pricing program. This bill seeks to ensure that health carriers and pharmacy benefits managers do not discriminate against covered entities or specified pharmacies participating in the 340B program with regard to reimbursement practices. Essentially, the bill establishes that these entities must receive reimbursements that are not less than those given to similarly situated pharmacies that do not participate in the 340B program.
Despite its potential benefits, the bill may face contention from various stakeholders in the healthcare sector. Opponents might argue that the bill could complicate reimbursement processes and lead to increased costs for health carriers. Additionally, there may be concerns about the broad scope of the bill, particularly regarding how it defines discrimination and the specific terms and conditions imposed on pharmacies, which could result in unintended consequences for consumers and providers alike.